Merck signs MoU with MOTIE and Daejeon City, South Korea for Asia-Pacific Bioprocessing Centre
The planned bioprocessing facility would support commercial manufacturing for biotech and pharmaceutical customers across Asia-Pacific
MOTIE | 08/05/2023 | By Sudeep Soparkar | 680
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy